22nd Century Change in Assets/Liabilities 2011-2025 | XXII
22nd Century change in assets/liabilities from 2011 to 2025. Change in assets/liabilities can be defined as represents any other changes in assets/liabilities
22nd Century Annual Change in Assets/Liabilities
(Millions of US $) |
| 2024 |
$-2 |
| 2023 |
$-1 |
| 2022 |
$0 |
| 2021 |
$-2 |
| 2020 |
$1 |
| 2019 |
$1 |
| 2018 |
$0 |
| 2017 |
$-1 |
| 2016 |
$0 |
| 2015 |
$0 |
| 2014 |
$0 |
| 2013 |
$0 |
| 2012 |
$0 |
| 2011 |
$0 |
| 2010 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Tobacco Products |
$0.002B |
$0.024B |
|
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
|
